Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

NCT00103571 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00103571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2004
Completion date
August 31, 2006
Enrollment
600
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia